Positive Expression of LSD1 and Negative Expression of E-cadherin Correlate with Metastasis and Poor Prognosis of Colon Cancer
- 12 January 2013
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 58 (6) , 1581-1589
Abstract
Background The first identified lysine-specific demethylase, LSD1, plays an important role in the metastatic progression of several types of cancer. Aims The aim of this study was to investigate LSD1, E-cadherin, and N-cadherin expression in colon cancer specimens and their clinical significance. Methods The expression of LSD1, E-cadherin, and N-cadherin in colon cancer specimens was determined by immunohistochemistry, and the relationship between the expression of the respective molecules and clinicopathological characteristics was analyzed. Results The positive expression rates of LSD1, E-cadherin, and N-cadherin in colon cancer specimens were 66.7 % (72/108), 85.2 % (92/108), and 41.7 % (45/108), respectively. LSD1 was significantly more highly expressed in colon cancer specimens classified as high TNM stage lesions and with distant metastasis (P < 0.05). Further analysis demonstrated that LSD1 expression was positively correlated with lymph node and distant metastases (P < 0.05). However, E-cadherin expression was significantly downregulated in colon cancer specimens classified as high TNM stage lesions and with distant metastasis (P < 0.05), whereas the expression of N-cadherin did not differ significantly according to clinical and pathological characteristics (P > 0.05). Correlation analysis revealed that LSD1 expression was negatively correlated with E-cadherin expression (r s = −0.318, P = 0.001), but not evidently correlated with N-cadherin expression (r s = 0.182, P = 0.06). Colon cancer specimens with positive LSD1 expression and negative E-cadherin expression were correlated with significantly lower overall survival. Conclusions LSD1 showed a significantly higher expression, in contrast to the significantly lower expression of E-cadherin, in colon cancer specimens classified as high TNM stage lesions and with distant metastasis. Positive expression of LSD1 and negative expression of E-cadherin may be predictors of a worse colon cancer prognosis.Keywords
This publication has 50 references indexed in Scilit:
- Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancerMolecular Carcinogenesis, 2011
- Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transitionOncogene, 2010
- Snail1 links transcriptional control with epigenetic regulationThe EMBO Journal, 2010
- The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1The EMBO Journal, 2010
- LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast CancerCell, 2009
- Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genesProceedings of the National Academy of Sciences, 2007
- The epigenetic progenitor origin of human cancerNature Reviews Genetics, 2006
- An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylationNature, 2005
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000